News
Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...
The use of intermittent scanning continuous glucose monitoring improves glycaemic control outcomes in older adult patients ...
In the coming years the continuous glucose monitoring systems products market is expected to reach USD12,835.6 million by ...
CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...
Glucotrack, Inc. (NASDAQ: GCTK) is focused on the design, development, and commercialization of novel technologies for people with diabetes. The Company is currently developing a long-term implantable ...
Introduction. Blood glucose monitors are medical devices used to determine the blood glucose level needed for the effective management of ...
In the past 5 years, what change has had the greatest impact on HbA1c in diabetes care? Is it continuous glucose monitoring?
Abbott’s FreeStyle Libre continuous glucose monitoring technology is associated with a significant reduction in the risk of hospitalization for heart complications in people with diabetes, according ...
Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Ex ...
Learn how emerging technologies are enhancing patient engagement and treatment strategies in everyday practice.
Emma Gill had bee been warned about her blood sugar levels being too high before, so she tested out a continuous glucose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results